title: Exhaled nitric oxide.
abstract: Nitric oxide (NO) is now considered an important biomarker for respiratory disease. Studies have confirmed that the fractional concentration of exhaled nitric oxide (FENO) is elevated in the airways of patients who have asthma in comparison with controls. The level of FENO correlates well with the presence and level of inflammation, and decreases with glucocorticoid treatment. NO has potential to be used not only as a diagnostic aid but also as a management tool for assessing severity, monitoring response to therapy, and gaining control of asthma symptoms. This article reviews the biology of NO and its role in respiratory disease.
authors.affiliation: Allergy & Asthma Care and Prevention Center, Lone Tree, CO 80204, USA.
authors.forename: Lora
authors.initials: L
authors.lastname: Stewart
authors.forename: Rohit K
authors.initials: RK
authors.lastname: Katial
mesh_terms: D045853:Exhalation; D006801:Humans; D009569:Nitric Oxide / Q000032:analysis* / Q000378:metabolism; D012140:Respiratory Tract Diseases / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy
chemical_list: D009569:Nitric Oxide